Filing Details
- Accession Number:
- 0001628280-23-026750
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-02 16:05:37
- Reporting Period:
- 2023-07-31
- Accepted Time:
- 2023-08-02 16:05:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1932393 | Ge Healthcare Technologies Inc. | GEHC | X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844) | 882515116 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1951605 | Michael Kevin O'neill | 500 W. Monroe Street Chicago IL 60661 | Ceo, Pdx | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.01 Per Share | Disposition | 2023-07-31 | 2,334 | $76.55 | 24,025 | No | 4 | S | Direct | |
| Common Stock, Par Value $0.01 Per Share | Acquisiton | 2023-07-31 | 13,275 | $40.40 | 37,300 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.01 Per Share | Disposition | 2023-07-31 | 13,275 | $77.46 | 24,025 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.01 Per Share | Employee Stock Option (right to buy) | Disposition | 2023-07-31 | 13,275 | $0.00 | 13,275 | $40.40 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2028-12-21 | No | 4 | M | Direct |
Footnotes
- The price reported represents the weighted average price of shares sold. These shares were sold in multiple transactions at prices ranging from $76.55 to $76.59, inclusive. The Reporting Person undertakes to provide to GE HealthCare, any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).
- Includes sale of approximately 6,923 shares of GE HealthCare common stock to cover the exercise price of the stock options.
- The price reported represents the weighted average price of shares sold. These shares were sold in multiple transactions at prices ranging from $77.45 to $77.55, inclusive. The Reporting Person undertakes to provide to GE HealthCare, any security holder of GE HealthCare, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3).
- Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis, of which 100% are fully exercisable immediately.
Billionaire Hedge Funds
